Cancer Clinical Investigators Should Converge with Pharmacometricians

Clin Cancer Res. 2019 Sep 1;25(17):5182-5184. doi: 10.1158/1078-0432.CCR-19-1067. Epub 2019 Jun 27.

Abstract

The applied quantitative science pharmacometrics has significantly enhanced cancer therapeutics development. Pharmacometrics is now improving our understanding of complex diagnostics. Through the concept of convergence and methods of quantitative and systems pharmacology, pharmacometrics is poised to interconnect mathematical models of disease and therapy to advance cancer care.See related article by Colomban et al., p. 5342.

Publication types

  • Comment

MeSH terms

  • Carcinoma, Ovarian Epithelial*
  • Female
  • Humans
  • Kinetics
  • Ovarian Neoplasms*
  • Research Personnel